Antibiotics for community‐acquired pneumonia in children
47 results
1 - 47
Antibiotics for community‐acquired pneumonia in children
Comparison of different antibiotics for community acquired pneumonia in children - Antibiotics for community‐acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
Five days of antibiotic therapy is comparable with 10 days in children with community-acquired pneumonia (SAFER)- Comparable outcomes with 5 days and 10 days of antibiotics in children with community-acquired pneumonia (SCOUT-CAP)
- Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months
- Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months
- Short-course versus long-course antibiotic therapy for (by WHO algorithm) non-severe community-acquired pneumonia in children aged 2 months to 59 months in developing countries
- Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia
- Antibiotics for community‐acquired pneumonia in adult outpatients
- Antibiotics for lower respiratory tract infections secondary to M. pneumoniae in children
- Antibiotics for hospital‐acquired pneumonia in neonates and children
- Amoxicillin for children with CAP: low-dose for 3 days is noninferior to high-dose for 7 days (CAP-IT)
- Corticosteroids for pneumonia
- Guidelines for pediatric pneumonia from BTS
- Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
- SR: Short courses of antibiotics as effective as longer courses for outpatient infections